Sesame Care Review
Best for: Brand-name GLP-1 buyers (Wegovy or Zepbound) who want LillyDirect-grade cash pricing on Zepbound vials/KwikPens or NovoCare-style first-two-month promo pricing on Wegovy without compounding risk, AND who value the ability to browse named providers with displayed prices before booking. Especially well-suited for patients in the 41 states with included lab work, patients with commercial insurance willing to pursue prior authorization for $25/mo medication access, and patients who want a single platform for weight-loss + adjacent specialties (mental health, dermatology, women's health). NOT appropriate for buyers seeking compounded GLP-1s at the $99-$249/mo budget tier (Sesame is brand-name-only for GLP-1s), buyers who require provider credentials curated and vetted by a single medical group rather than an independently-operated marketplace, or buyers in the 9 lab-excluded states unwilling to bear separate lab costs.
Multi-product telehealth MARKETPLACE (Sesame, Inc.) — fundamentally different from every other WLR-listed weight-loss provider. Sesame is NOT a stocked formulary like Hims/Henry/Ro/SkinnyRx; it is a transparent-pricing booking layer that connects patients directly with independently-owned and -operated provider practices across multiple specialties (urgent care, weight loss, mental health, dermatology, women's health, erectile dysfunction, pediatrics, prescription refills). The weight-loss vertical is branded 'Success by Sesame' and uses a subscription model: $39-$99/month for clinical care (Month-to-Month $99, 3-Month $39/mo, 6-Month $49/mo, Annual $59/mo) that covers video visits, unlimited provider messaging, follow-up visits, and lab work in most states — BUT medication is billed separately at brand-name cash-pay rates. Sesame holds a LillyDirect pharmacy partnership for Zepbound cash pricing ($299 vials at 2.5mg up to $449 at 7.5-15mg; KwikPens $299-$699) and offers Wegovy through manufacturer self-pay channels ($199/mo first two months for new self-pay patients at lowest dose, then $349/mo standard, via promo expiring 2026-06-30). Additional GLP-1 inventory: Wegovy pill ($149/mo low doses 1.5mg/4mg, $299/mo high doses 9mg/25mg), Foundayo orforglipron oral, Rybelsus oral semaglutide, plus Ozempic and Mounjaro off-label, plus non-GLP-1 weight-loss agents Saxenda, Contrave, Orlistat, and Metformin. Marketplace prescriber pool is 80+ providers spanning MD/DO/NP/FNP/PA/APRN/DNP/PMHNP/CRNP credentials. Trust signals: BBB-accredited, LegitScript-verified, lab work via Quest Diagnostics (excluded in AZ/HI/ND/NJ/NY/OK/RI/SD/WY). Multi-payout Katalys program PENDING approval ($175 weight loss, $80 ED, $140 mental health) — affiliate_url is bare https://sesamecare.com until tracking URL is issued.
Medium confidence · Last verified 2026-05-28 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Sesame Care is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Sesame Care prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Success by Sesame subscription (Annual plan) | subscription | $59 |
| 0.25-0.5mg starting (new self-pay patients, lowest strength, promo through 2026-06-30) | branded subcutaneous pen | $199 |
| 1.5mg / 4mg low doses | branded oral tablet | $149 |
| 9mg / 25mg high doses | branded oral tablet | $299 |
| 2.5mg vial | branded subcutaneous vial (LillyDirect partnership) | $299 |
| 5mg vial | branded subcutaneous vial (LillyDirect partnership) | $399 |
| 7.5mg-15mg vial | branded subcutaneous vial (LillyDirect partnership) | $449 |
| 2.5mg KwikPen | branded subcutaneous pen (LillyDirect partnership) | $299 |
| 5mg KwikPen | branded subcutaneous pen (LillyDirect partnership) | $399 |
| 7.5mg KwikPen | branded subcutaneous pen (LillyDirect partnership) | $499 |
| 10mg-15mg KwikPen | branded subcutaneous pen (LillyDirect partnership) | $699 |
| With commercial insurance coverage | branded (varies) | $25 |
✓ Pros
- •Marketplace transparency — patients pick a specific named provider with displayed price BEFORE booking, unlike most telehealth providers where the prescribing clinician is opaque until after intake
- •BBB-accredited AND LegitScript-verified — trust trifecta complete (only LegitScript-verified compounding partner is missing, but Sesame's GLP-1 supply is branded via LillyDirect/NovoCare, not compounded)
- •LillyDirect partnership unlocks Zepbound vial and KwikPen cash pricing that matches Lilly's lowest-disclosed direct-to-consumer rates ($299 at lowest dose) — no other WLR-listed provider has this verified partnership
- •Wegovy self-pay promo ($199/mo for first two months, lowest dose, new self-pay only) is one of the lowest brand-Wegovy cash prices in the WLR directory through 2026-06-30
- •Subscription model is honest about scope — clinical care only, medication billed separately — vs. compounded-GLP-1 providers that bundle the two and obscure the medication's actual cost basis
- •Wegovy pill ($149/mo low doses) and Foundayo orforglipron are both stocked — Sesame is one of few providers offering both oral semaglutide AND orforglipron alongside injectables
- •Lab work included in subscription for 41 states (excludes AZ/HI/ND/NJ/NY/OK/RI/SD/WY)
- •Insurance route ($25/mo possible) is genuinely viable — providers assist with prior authorization paperwork, not just a marketing line
- •Cross-vertical platform means established patients can stay in-network for ED, mental health, women's health follow-ups — engagement and retention advantage
- •Eligibility criteria disclosed transparently (BMI 30+ or 27+ with comorbidity; standard MTC/MEN2/pancreatitis/Type 1 exclusions for GLP-1)
✗ Cons
- •Marketplace model means the prescribing clinician's credentials, malpractice history, and state licensure are the INDIVIDUAL provider's, not Sesame's — quality varies provider to provider in a way that does not apply to single-physician-group competitors
- •States_available CANNOT be enumerated at the platform level — depends entirely on which providers in the marketplace are licensed in a given state — left empty per WLR data-discipline rule for marketplace operators
- •No pharmacy ownership — Sesame does not operate its own dispensing pharmacy; fulfillment is split between LillyDirect (Zepbound), NovoCare (Wegovy self-pay), and the patient's preferred retail pharmacy depending on the medication and the patient's insurance
- •Refund policy is restrictive: full refund only if cancellation occurs at least 3 hours prior to initial visit; no refunds for first month if initial visit occurred; previously-paid months are non-refundable
- •Subscription requires commitment — no genuine pay-per-visit option for the weight-loss vertical even though Sesame's broader urgent-care platform is famously per-visit
- •Limited-time Wegovy promo ($199/mo) gates on (a) new self-pay patient status, (b) lowest dose strength (0.25mg/0.5mg) only, (c) standard $349/mo applies after month 2 — a structurally honest disclosure but the headline price is the floor, not the average
- •Wegovy pill high-dose pricing ($299/mo for 9mg/25mg) is roughly 2x the low-dose price — patients titrating up the oral semaglutide ladder face material month-over-month cost increases
- •Zepbound KwikPen high-dose pricing ($699/mo for 10mg-15mg) approaches Lilly's list price — the LillyDirect discount narrows significantly at higher doses
- •Lab work excluded in 9 jurisdictions (AZ/HI/ND/NJ/NY/OK/RI/SD/WY) — patients in those states bear lab cost separately on top of the subscription
- •No published medical-director name or chief-medical-officer biography on the public site — marketplace by design means no single physician owns clinical governance
- •Katalys multi-payout offer ($175/$80/$140) is PENDING approval — affiliate_url is bare sesamecare.com until tracking URL with offer_id and aff_id parameters is issued
- •Existing _id 'sesame' record (added 2026-04-07) is a stale 'compounded' stub that mis-classifies Sesame's brand-only GLP-1 model — recommend deprecating that record in a follow-up pass to avoid duplicate surfacing on /compare and /best pages
Ready to start with Sesame Care?
Starting at $25/month. See current pricing and start your free consultation.
Sources & methodology
Our Sesame Care review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Sesame Care
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-oriented patients who want compounded GLP-1 alongside hormone and performance programs from a 25-year-old established brand
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Sesame Care?
Starting at $25/month. See current pricing and start your free consultation.